NovaBay Pharmaceuticals reported a net loss of $4.9 million, or $0.07 per share, in the second quarter compared to a $2.9 million net loss, or $0.06 per share, in the same quarter of 2014, according to a company press release. Total revenue was reporte…
(MedPage Today) — Nearly three-fourths think drug prices are unreasonable
The FDA has accepted for review a new drug application for BromSite, according to a press release from InSite Vision.The FDA assigned a Prescription Drug User Fee Act action date of April 10, 2016.
(MedPage Today) — $175 million per year spent on preventable infections, agency says
LONDON–(BUSINESS WIRE)–Technavio has published a new report on the vision care market in the US, which is expected to grow at a CAGR of more than 5% from 2015-2019.
Although there is a discernable trend of young eye surgeons settling for durable non-owner associate positions in institutional, staff-model HMO and closely held private practices, most of the peri-graduates I speak with would strongly prefer to eventually be a shareholder. And private independent practice is still, by far, the dominant enterprise model in ophthalmology and will remain so for many years to come.Accordingly, it is useful to review the typical 10-point timeline of events from one’s late residency or fellowship to employment and on through your early years as an owner.